Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Symptomatic management in multiple sclerosis.
Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis.
White and gray matter damage in primary progressive MS: The chicken or the egg?
Comparing Face-to-Face and Online Qualitative Research With People With Multiple Sclerosis.
The use of valproic acid and multiple sclerosis.
An observational study of venoplasty in patients with multiple sclerosis.
Interleukin-12p40 in the spinal fluid as a biomarker for clinically isolated syndrome.
Optic Neuritis as Isolated Manifestation of Leptomeningeal Carcinomatosis: A Case Report and Systematic Review of Ocular Manifestations of Neoplastic Meningitis.
Multiple sclerosis rehabilitation.
Poster Abstracts from the Fourth International Symposium on Gait and Balance in Multiple Sclerosis: The Role of CognitionCleveland Clinic • Cleveland, Ohio, USA • October 10 & 11, 2014.
Proteomics of a conundrum: thoughts on addressing the aetiology vs. progression of Multiple Sclerosis.
A New Zealand pilot randomized controlled trial of a web-based interactive self-management programme (MSInvigor8) with and without email support for the treatment of multiple sclerosis fatigue.
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.
Measures of aging with disability in U.S. secondary data sets: Results of a scoping review.
Pregnancy Does Not Prove Neuroprotective for Women with MS Who Stop Taking Natalizumab
Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis.
Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases.
Midkine and multiple sclerosis.
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes.
Implicit memory in multiple sclerosis.
MS nurses join project to prove the value of specialist role.
'It feels like someone is hammering my feet': Understanding pain and its management from the perspective of people with multiple sclerosis.
Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk.
Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis.
Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients.
Pages
« first
‹ previous
…
515
516
517
518
519
520
521
522
523
…
next ›
last »